The Zacks Basic Materials sector has held up relatively well in 2022, down roughly 11% and outperforming the S&P 500 by a fair margin.
A big-time player in the realm, Albemarle (ALB - Free Report) , is on deck to unveil quarterly earnings on November 2nd, after the market close.
Albemarle is a leading producer of highly-engineered specialty chemicals with three reportable segments: Lithium, Bromine, and Catalysts.
Currently, the company sports a favorable Zacks Rank #1 (Strong Buy) paired with an overall VGM Score of an F.
How does everything else stack up heading into the print? Let’s take a closer look.
Share Performance & Valuation
ALB shares have been notably strong in 2022, up more than 20% and widely outperforming the S&P 500.
Over the last three months, Albemarle shares have continued on their market-beating trajectory, tacking on more than 15% in value and again outperforming the S&P 500.
Albemarle shares trade at a 13.1X forward earnings multiple, nowhere near the 19.1X five-year median and reflecting a 71% premium relative to the Zacks Basic Materials sector average.
The company carries a Value Style Score of a D.
Quarterly Estimates
Analysts have been bullish in their earnings outlook, with three positive earnings estimate revisions coming in over the last several months. The Zacks Consensus EPS Estimate of $6.84 indicates a Y/Y uptick of a massive 550%.
The company’s top-line is in great shape also; the Zacks Consensus Sales Estimate of $2.1 billion suggests a year-over-year uptick of more than a triple-digit 150%.
Quarterly Performance & Market Reactions
Albemarle is on an impressive earnings streak, exceeding both revenue and earnings estimates in four consecutive quarters.
Just in its latest print, the company penciled in a 14% bottom-line beat and an 8% revenue beat. Below is a chart illustrating the company’s revenue on a quarterly basis.
Additionally, the market has had mixed reactions in response to the company’s quarterly results, with shares moving downwards twice and upwards twice following its last four prints.
Putting Everything Together
ALB shares have been notably strong in 2022, outperforming the general market across several timeframes.
The company’s forward P/E ratio sits well beneath its five-year median but is above its Zacks Sector average.
Analysts have been bullish in their earnings outlook, and estimates suggest substantial Y/Y upticks in both revenue and earnings.
The company has consistently exceeded quarterly estimates, with the market having mixed reactions following its last four releases.
Heading into the print, Albemarle (ALB - Free Report) carries a Zacks Rank #1 (Strong Buy) with an Earnings ESP Score of 3.6%.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
The Zacks Basic Materials sector has held up relatively well in 2022, down roughly 11% and outperforming the S&P 500 by a fair margin.
A big-time player in the realm, Albemarle (ALB - Free Report) , is on deck to unveil quarterly earnings on November 2nd, after the market close.
Albemarle is a leading producer of highly-engineered specialty chemicals with three reportable segments: Lithium, Bromine, and Catalysts.
Currently, the company sports a favorable Zacks Rank #1 (Strong Buy) paired with an overall VGM Score of an F.
How does everything else stack up heading into the print? Let’s take a closer look.
Share Performance & Valuation
ALB shares have been notably strong in 2022, up more than 20% and widely outperforming the S&P 500.
Over the last three months, Albemarle shares have continued on their market-beating trajectory, tacking on more than 15% in value and again outperforming the S&P 500.
Albemarle shares trade at a 13.1X forward earnings multiple, nowhere near the 19.1X five-year median and reflecting a 71% premium relative to the Zacks Basic Materials sector average.
The company carries a Value Style Score of a D.
Quarterly Estimates
Analysts have been bullish in their earnings outlook, with three positive earnings estimate revisions coming in over the last several months. The Zacks Consensus EPS Estimate of $6.84 indicates a Y/Y uptick of a massive 550%.
The company’s top-line is in great shape also; the Zacks Consensus Sales Estimate of $2.1 billion suggests a year-over-year uptick of more than a triple-digit 150%.
Quarterly Performance & Market Reactions
Albemarle is on an impressive earnings streak, exceeding both revenue and earnings estimates in four consecutive quarters.
Just in its latest print, the company penciled in a 14% bottom-line beat and an 8% revenue beat. Below is a chart illustrating the company’s revenue on a quarterly basis.
Additionally, the market has had mixed reactions in response to the company’s quarterly results, with shares moving downwards twice and upwards twice following its last four prints.
Putting Everything Together
ALB shares have been notably strong in 2022, outperforming the general market across several timeframes.
The company’s forward P/E ratio sits well beneath its five-year median but is above its Zacks Sector average.
Analysts have been bullish in their earnings outlook, and estimates suggest substantial Y/Y upticks in both revenue and earnings.
The company has consistently exceeded quarterly estimates, with the market having mixed reactions following its last four releases.
Heading into the print, Albemarle (ALB - Free Report) carries a Zacks Rank #1 (Strong Buy) with an Earnings ESP Score of 3.6%.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on ALB - FREE